Meridian Investment Counsel’s Bristol-Myers Squibb BMY Stock Holding History

Meridian Investment Counsel’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$207K	Hold	3,584	–	–	0.04%	242
2026 Q1	$217K	Buy	+3,584	New	+$209K	0.05%	229
2025 Q2	–	Sell	-3,584	Closed	-$219K	–	225
2025 Q1	$219K	Hold	3,584	–	–	0.06%	204
2024 Q4	$203K	Buy	+3,584	New	+$200K	0.06%	207
2024 Q2	–	Sell	-5,332	Closed	-$289K	–	214
2024 Q1	$289K	Buy	5,332 +31	+0.6%	+$1.58K	0.1%	178
2023 Q4	$272K	Hold	5,301	–	–	0.09%	182
2023 Q3	$308K	Hold	5,301	–	–	0.12%	164
2023 Q2	$339K	Hold	5,301	–	–	0.12%	158
2023 Q1	$367K	Sell	5,301 -26	-0.5%	-$1.83K	0.14%	150
2022 Q4	$383K	Hold	5,327	–	–	0.15%	142
2022 Q3	$379K	Sell	5,327 -527	-9%	-$38.2K	0.17%	131
2022 Q2	$451K	Hold	5,854	–	–	0.19%	122
2022 Q1	$428K	Hold	5,854	–	–	0.15%	146
2021 Q4	$365K	Hold	5,854	–	–	0.12%	158
2021 Q3	$346K	Hold	5,854	–	–	0.13%	152
2021 Q2	$391K	Hold	5,854	–	–	0.14%	147
2021 Q1	$370K	Hold	5,854	–	–	0.14%	142
2020 Q4	$363K	Hold	5,854	–	–	0.15%	136
2020 Q3	$353K	Hold	5,854	–	–	0.17%	119
2020 Q2	$344K	Hold	5,854	–	–	0.18%	117
2020 Q1	$326K	Hold	5,854	–	–	0.21%	109
2019 Q4	$376K	Buy	+5,854	New	+$335K	0.19%	118
2016 Q4	–	Sell	-3,817	Closed	-$206K	–	171
2016 Q3	$206K	Hold	3,817	–	–	0.14%	153
2016 Q2	$281K	Hold	3,817	–	–	0.19%	134
2016 Q1	$244K	Hold	3,817	–	–	0.17%	139
2015 Q4	$263K	Hold	3,817	–	–	0.19%	127
2015 Q3	$226K	Hold	3,817	–	–	0.19%	126
2015 Q2	$254K	Hold	3,817	–	–	0.18%	129
2015 Q1	$246K	Hold	3,817	–	–	0.17%	133
2014 Q4	$225K	Buy	+3,817	New	+$215K	0.16%	135

Other funds holding BMY

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

AIM

Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

FWIA

Fort Washington Investment Advisors Cincinnati, Ohio $19.9B AUM 22.19% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

DLA

Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return

Meridian Investment Counsel's BMY Position: Q2 2026 in Review

Meridian Investment Counsel held its Bristol-Myers Squibb (BMY) position steady in Q2 2026 at 3,584 shares worth $207K. The position accounts for 0.04% of the portfolio, ranked #242.

Meridian Investment Counsel first reported a position in BMY in Q4 2014 and has held it in 30 quarters since. The position peaked at $451K in Q2 2022. 1,086 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

Meridian Investment Counsel held 3,584 shares of Bristol-Myers Squibb worth $207K as of Q2 2026.
Meridian Investment Counsel left its Bristol-Myers Squibb share count unchanged in Q2 2026.
Bristol-Myers Squibb made up 0.04% of Meridian Investment Counsel's portfolio in Q2 2026, its #242 holding.
Meridian Investment Counsel first reported a position in Bristol-Myers Squibb in Q4 2014 and has held it in 30 quarters since.
Meridian Investment Counsel's Bristol-Myers Squibb position peaked at $451K in Q2 2022.
1,086 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Meridian Investment Counsel's 13F filing for Q2 2026, filed 23 Jul 2026.